Skip to main content

Semantic Decision-Making Corrupted in MCI, AD


Patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) are consistently slower and less accurate than healthy control persons in making semantic decisions in response to stimuli with words and images, new research shows.
Brady Kirchberg and colleagues at Hofstra North Shore–Long Island Jewish School of Medicine, Manhasset, New York, found that both MCI and AD groups were not only less accurate and slower than healthy control participants in making semantic decisions in response to word stimuli but also that the deficit worsened as the sizes of the objects being compared became more similar.
When line drawings were used as stimuli, the size of the drawings themselves had an undue influence upon semantic knowledge judgments in the 2 groups, investigators add.
Performance on the semantic distance task was also a "strong and significant" predictor of everyday functional capacity.
Dr. Terry Goldberg
"When MCI/AD patients have to make decisions about the size of real-world objects, they are less accurate than controls, and that gets amplified when they have to make fine-grained decisions about the size of these things in the real world," Terry Goldberg, PhD, who was the principle investigator of the study, toldMedscape Medical News.
"So making these size distinctions becomes increasingly more difficult for patients with MCI and AD, and we think it's because semantic knowledge gets corrupted with advancing disease, especially disease in the temporal lobe."
The study was published in the December issue of the American Journal of Psychiatry.
Semantic Processing
For the study, investigators studied semantic processing in 25 patients with amnestic MCI; 27 with mild to moderate AD; and 70 healthy control participants.
To do so, they used a novel paradigm that does not require overt word retrieval but rather capitalizes on "distance effects" in the semantic system.
Semantic memory was then assessed using a semantic distance task in which participants had to judge which of 2 entities, presented as images or words, was larger in the real world.
Semantic distance was also manipulated by adjusting the disparity in real-world size between the 2 entities that were being compared.
Images were also presented either as "congruent," in which the image of the larger real-world object was larger than the image of the smaller object, or "incongruent," in which the image of the smaller object was larger than the image of the larger object.
In addition to their main findings, investigators observed that the MCI/AD groups each had disproportionately more difficulty than control participants when making accurate responses in comparisons involving small semantic distances.
The same 2 groups were also disproportionately slower in making responses to contrasts involving small semantic distances.
Collapsing across image congruency conditions, the MCI/AD groups also demonstrated steeper declines in performance as they went from easier to harder small-distance conditions.
Across this task, performance declined 8 percentage points for healthy control participants, 11 percentage points for the MCI group, and 12 percentage points for the AD group.
Critically, investigators add, abnormalities in semantic processing were related to compromises in everyday functional competence as measured by the UCSD Performance-Based Skills Assessment tool.
"You could say these people had a word finding problem — they knew the answers, they just couldn't find the word, but this was nonverbal, so it's not that people can't come up with the word," Dr. Goldberg said.
"So this reflects loss of knowledge — they once had knowledge, but because of disease, the neurons become less functional, and they die. At the same time, we showed this kind of processing impairment compromises how a person does in terms of everyday function, so these problems impact on daily function for the worse."
The "Incongruent Condition"
In an accompanying editorial, David Salmon, PhD, University of California, San Diego, pointed out that the image effect observed between the 3 groups in the study was largely driven by the incongruent condition.
In the incongruent condition, "patients with mild cognitive impairment performed similarly to healthy subjects in tasks with large semantic distances and similarly to Alzheimer's disease patients in tasks with the more semantically demanding small distances."
Nevertheless, the deficits in semantic memory shown in this study "add confidence to the growing perception that subtle decline in this cognitive domain occurs in patient with amnestic mild cognitive impairment," Dr. Salmon observed.
He also suggested that decrements in semantic memory as seen in MCI patients in this study suggest that loss of semantic knowledge may be an important reason for this decline, insofar as early loss of semantic knowledge may contribute to a decline in judgment.
The study was funded by the Feinstein Institute for Medical Research and the Litwin-Zucker Center for Research in Alzheimer's Disease and Memory Disorders. Dr. Goldberg received an investigator-initiated grant from Pfizer/Eisai.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n...